Modal Title
Welcome to the newly renewed CosmeRNA Official Store.
Discover a more refined shopping experience, improved navigation and clearer product guidance—designed to help you choose the most suitable CosmeRNA scalp and hair solutions with confidence.
We look forward to supporting your hair and scalp journey through science-driven innovation!
New York Post highlights cutting-edge hair care and treatment innovation in South Korea
Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia
A 2025 clinical research article published in Clinical and Experimental Dermatology and Therapies reports the results of a six-month, double-blind, randomized, placebo-controlled trial evaluating CosmeRNA ARI in adults with androgenetic alopecia in Germany.
Read moreabout Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia
EADV Congress 2025 – Hair and Nail Disorders Abstract Book
A clinical research abstract presented at the EADV Congress 2025 reported findings from a randomised, double-blind, placebo-controlled study investigating an androgen-receptor-regulating topical approach in women with female pattern hair loss.
Read moreabout EADV Congress 2025 – Hair and Nail Disorders Abstract Book
Share:
ITN Business features Bioneer’s CosmeRNA
Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia – Scientific Reports (2022)
1 comment
leaving comment for test